Mobile Trading

TRANSGENE BIOTEK LTD.

NSE : NABSE : 526139ISIN CODE : INE773D01018Industry : Hospital & Healthcare ServicesHouse : Private
BSE7.490.16 (+2.18 %)
PREV CLOSE ( ) 7.33
OPEN PRICE ( ) 7.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6992
TODAY'S LOW / HIGH ( )7.16 7.90
52 WK LOW / HIGH ( ) 5.7912.46
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.09-0.79-1.37-1.38-1.45
   CEPS(Rs)-0.07-0.14-0.06-0.07-0.14
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.411.502.292.944.31
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-258.11-1107.62-531.84-308.130.00
   EBIT Margin(%)-219.63-9773.140.00-5994.440.00
   Pre Tax Margin(%)-279.050.000.00-6154.340.00
   PAT Margin (%)-279.050.000.00-6154.340.00
   Cash Profit Margin (%)-239.76-1921.05-550.95-310.610.00
Performance Ratios
   ROA(%)-0.46-4.15-6.84-6.45-6.39
   ROE(%)-5.94-41.80-52.51-38.00-28.73
   ROCE(%)-2.10-19.99-32.32-26.55-22.10
   Asset Turnover(x)0.000.000.000.00
   Sales/Fixed Asset(x)0.000.000.000.00
   Working Capital/Sales(x)-0.02-0.01-0.01-0.010.00
Efficiency Ratios
   Fixed Capital/Sales(x)458.091952.921241.19634.570.00
   Receivable days13.0555.8035.5618.18862.22
   Inventory Days52.60425.35242.3663.443548.64
   Payable days0.001187.70-1746.921857.708270.20
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-109.51-17.82-57.27-65.89-21.41
   Price/Book(x)5.761.661.571.560.70
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)322.14580.33453.84271.369256.18
   EV/Core EBITDA(x)-178.64-73.53-158.30-180.05-48.35
   EV/EBIT(x)-146.68-5.94-3.87-4.53-3.13
   EV/CE(x)3.061.310.270.290.20
   M Cap / Sales262.57342.41315.51204.686378.80
Growth Ratio
   Net Sales Growth(%)326.32-36.44-48.874642.12-94.98
   Core EBITDA Growth(%)2.60-74.982.7362.67-150.16
   EBIT Growth(%)90.4247.07-0.093.95-24.05
   PAT Growth(%)89.0942.240.314.81-24.67
   EPS Growth(%)89.0942.230.324.81-24.67
Financial Stability Ratios
   Total Debt/Equity(x)1.311.150.690.510.32
   Current Ratio(x)0.100.100.080.050.05
   Quick Ratio(x)0.100.100.070.040.05
   Interest Cover(x)-3.70-8.64-44.40-37.49-27.78
   Total Debt/Mcap(x)0.230.700.440.330.45

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.